These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 30502644)

  • 1. Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal.
    Weinkle L; Domen CH; Shelton I; Sillau S; Nair K; Alvarez E
    Mult Scler Relat Disord; 2019 Jan; 27():383-390. PubMed ID: 30502644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada.
    Hildebrand A; Minnier J; Cameron MH
    Mult Scler Relat Disord; 2020 Feb; 38():101516. PubMed ID: 31855842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Illegal cannabis use is common among Danes with multiple sclerosis.
    Gustavsen S; Søndergaard HB; Andresen SR; Magyari M; Sørensen PS; Sellebjerg F; Oturai AB
    Mult Scler Relat Disord; 2019 Aug; 33():5-12. PubMed ID: 31129415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
    Rice J; Cameron M
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cross-sectional survey of cannabis use by people with MS in Oregon and Southwest Washington.
    Rice J; Hildebrand A; Spain R; Senders A; Silbermann E; Wooliscroft L; Yadav V; Bourdette D; Cameron M
    Mult Scler Relat Disord; 2021 Oct; 55():103172. PubMed ID: 34332457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical cannabis use in Canadians with multiple sclerosis.
    Santarossa TM; So R; Smyth DP; Gustavsen DS; Tsuyuki DRT
    Mult Scler Relat Disord; 2022 Mar; 59():103638. PubMed ID: 35382939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing cannabis use in a sample of adults with multiple sclerosis and chronic pain: An observational study.
    Link K; Knowles LM; Alschuler KN; Ehde DM
    Mult Scler Relat Disord; 2023 Jul; 75():104742. PubMed ID: 37156034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of Medical Cannabis Use among Patients Diagnosed with Multiple Sclerosis.
    Guarnaccia JB; Khan A; Ayettey R; Treu JA; Comerford B; Njike VY
    Mult Scler Relat Disord; 2021 May; 50():102830. PubMed ID: 33636612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis use in people with Parkinson's disease and Multiple Sclerosis: A web-based investigation.
    Kindred JH; Li K; Ketelhut NB; Proessl F; Fling BW; Honce JM; Shaffer WR; Rudroff T
    Complement Ther Med; 2017 Aug; 33():99-104. PubMed ID: 28735833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of low-dose medical cannabis oils in multiple sclerosis.
    S G; Hb S; K L; R T; Bs R; Ps S; F S; Ab O
    Mult Scler Relat Disord; 2021 Feb; 48():102708. PubMed ID: 33387864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
    Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
    Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis and multiple sclerosis.
    Fragoso YD; Carra A; Macias MA
    Expert Rev Neurother; 2020 Aug; 20(8):849-854. PubMed ID: 32515670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation.
    Krcevski-Skvarc N; Wells C; Häuser W
    Eur J Pain; 2018 Mar; 22(3):440-454. PubMed ID: 29134767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of medical-grade cannabis in patients non-responders to Nabiximols.
    Saccà F; Pane C; Carotenuto A; Massarelli M; Lanzillo R; Florio EB; Brescia Morra V
    J Neurol Sci; 2016 Sep; 368():349-51. PubMed ID: 27538663
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple sclerosis, cannabis, and cognition: A structural MRI study.
    Romero K; Pavisian B; Staines WR; Feinstein A
    Neuroimage Clin; 2015; 8():140-7. PubMed ID: 26106538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacological effects of inhaled cannabis on pain in patients with multiple sclerosis: risks versus rewards.
    Maayah ZH; Dyck JRB
    Inflamm Res; 2020 Nov; 69(11):1073-1076. PubMed ID: 32860528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis use in people with multiple sclerosis and spasticity: A cross-sectional analysis.
    Rice J; Hugos C; Hildebrand A; Cameron M
    Mult Scler Relat Disord; 2020 Jun; 41():102009. PubMed ID: 32086163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis and cannabis: a cognitive and psychiatric study.
    Ghaffar O; Feinstein A
    Neurology; 2008 Jul; 71(3):164-9. PubMed ID: 18272863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users.
    Bonn-Miller MO; Boden MT; Bucossi MM; Babson KA
    Am J Drug Alcohol Abuse; 2014 Jan; 40(1):23-30. PubMed ID: 24205805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoids and bladder symptoms in multiple sclerosis.
    Kim-Fine S; Greenfield J; Chaput KH; Robert M; Metz LM
    Mult Scler Relat Disord; 2021 Sep; 54():103105. PubMed ID: 34216995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.